Free Trial

B. Riley Weighs in on InfuSystem's Q1 Earnings (NYSE:INFU)

InfuSystem logo with Medical background

InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) - B. Riley issued their Q1 2026 earnings per share (EPS) estimates for shares of InfuSystem in a report released on Thursday, May 8th. B. Riley analyst A. Schock anticipates that the company will post earnings of $0.04 per share for the quarter. B. Riley has a "Strong-Buy" rating on the stock. The consensus estimate for InfuSystem's current full-year earnings is $0.15 per share. B. Riley also issued estimates for InfuSystem's Q2 2026 earnings at $0.06 EPS, Q3 2026 earnings at $0.09 EPS and Q4 2026 earnings at $0.11 EPS.

INFU has been the topic of several other research reports. Sidoti raised InfuSystem to a "strong-buy" rating in a research note on Tuesday, March 18th. StockNews.com downgraded shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a research report on Wednesday.

View Our Latest Research Report on InfuSystem

InfuSystem Trading Up 1.3%

Shares of INFU traded up $0.08 during trading hours on Monday, reaching $6.08. 22,359 shares of the company traded hands, compared to its average volume of 126,483. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The firm has a market cap of $127.78 million, a price-to-earnings ratio of 101.35 and a beta of 1.73. The stock's fifty day moving average price is $5.26 and its 200 day moving average price is $7.13. InfuSystem has a 12-month low of $4.61 and a 12-month high of $9.97.

Hedge Funds Weigh In On InfuSystem

A number of institutional investors have recently modified their holdings of the stock. Minerva Advisors LLC grew its holdings in InfuSystem by 7.5% during the first quarter. Minerva Advisors LLC now owns 910,677 shares of the company's stock worth $4,899,000 after acquiring an additional 63,826 shares during the period. First Eagle Investment Management LLC grew its stake in shares of InfuSystem by 25.9% during the 4th quarter. First Eagle Investment Management LLC now owns 908,371 shares of the company's stock worth $7,676,000 after purchasing an additional 186,668 shares during the period. Meros Investment Management LP increased its holdings in shares of InfuSystem by 2.6% during the 4th quarter. Meros Investment Management LP now owns 631,105 shares of the company's stock valued at $5,333,000 after purchasing an additional 16,178 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of InfuSystem by 5.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 456,043 shares of the company's stock valued at $3,853,000 after purchasing an additional 21,697 shares during the period. Finally, Geode Capital Management LLC boosted its holdings in InfuSystem by 1.8% during the fourth quarter. Geode Capital Management LLC now owns 444,476 shares of the company's stock worth $3,756,000 after buying an additional 7,968 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company's stock.

InfuSystem Company Profile

(Get Free Report)

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Featured Stories

Earnings History and Estimates for InfuSystem (NYSE:INFU)

Should You Invest $1,000 in InfuSystem Right Now?

Before you consider InfuSystem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InfuSystem wasn't on the list.

While InfuSystem currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines